✦ LIBER ✦

Self-reported outcomes during treatment with tumour necrosis factor α inhibitors in patients with rheumatoid arthritis

✍ Scribed by Sidona-Valentina Bala; Kristina Forslind; Marie Edwinson Månsson

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 271 KB
Volume: 8
Category: Article
ISSN: 1478-2189
DOI: 10.1002/msc.163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor α antagonist use a

Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis

✍ Soko Setoguchi; Daniel H. Solomon; Michael E. Weinblatt; Jeffrey N. Katz; Jerry 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Improvement in patient-reported outcomes

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

✍ Keystone, E. ;Burmester, G. R. ;Furie, R. ;Loveless, J. E. ;Emery, P. ;Kremer, J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB 👁 2 views

Long-term treatment with methotrexate or

Long-term treatment with methotrexate or tumor necrosis factor α inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis

✍ Balandraud, Nathalie ;Guis, Sandrine ;Baptiste Meynard, Jean ;Auger, Isabelle ;R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

Association between the level of circula

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor

✍ Hubert Marotte; Béatrice Arnaud; Jennifer Diasparra; Saloua Zrioual; Pierre Mios 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Treatment with tumor necrosis factor inh

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

✍ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt Rantapää-Dahlqvist; Jo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 3 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients

Fcγ receptor type IIIA polymorphisms inf

Fcγ receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor α–blocking agents

✍ Zuhre Tutuncu; Arthur Kavanaugh; Nathan Zvaifler; Maripat Corr; Reena Deutsch; D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract ## Objective To determine whether polymorphisms in Fcγ receptor type IIIA (FcγRIIIA) correlate with clinical efficacy in patients with rheumatoid arthritis (RA) and patients with psoriatic arthritis (PsA) being treated with tumor necrosis factor α (TNFα) inhibitors. ## Methods The st